All People News articles – Page 5
-
NewsResearchers investigate bunyaviruses and picornaviruses in bid to stave off next pandemic
A $13 million per year grant will enable researchers to accelerate their investigations of bunyaviruses, which include life-threatening respiratory and hemorrhagic fever viruses, and picornaviruses, notably enterovirus D68.
-
NewsScientists awarded $90m to prep for future pandemics from understudied viruses
Scientists are laying the groundwork to rapidly respond to potential future pandemics caused by viruses from five understudied families, developing strategies and tools to produce vaccines and antibody-based therapies.
-
NewsSurvey finds epidemiologists believe viral and mosquito-borne pathogens are priority concerns for disease outbre
A new survey reveals that infectious disease experts point to viral pathogens and mosquito-borne pathogens as likely to spark outbreaks as humans, animals and viruses overlap; and new viruses are as concerning as changes to existing viruses.
-
NewsX.J. Meng receives prestigious MERIT Award to study hepatitis E virus
The Meng Lab will receive about $2 million over the next five years with the opportunity to seek approval to renew without undergoing regular peer review for five more years for up to $2.4 million, as the lab continues its cutting-edge research on hepatitis E virus.
-
NewsFred Hutch launches Atlas of Inspiring Hispanic/Latinx Scientists
To highlight and celebrate the many contributions of Hispanic and Latinx scientists, Fred Hutch Cancer Center has launched an Atlas of Inspiring Hispanic/ Latinx Scientists.
-
NewsWyss Institute selected to develop biologically engineered broad-spectrum antimicrobial therapeutic
The Wyss Institute for Biologically Inspired Engineering at Harvard University received a contract for up to $12M from the new SHIELD program which aims to develop a prophylactic treatment that can rapidly clear multiple bloodborne bacterial and fungal pathogens.
-
NewsCalls for more action to support vaccine uptake as new data shows two in three older people prioritise vaccine safety
A new report shows that overall trust in vaccines remains high among 50–70-year-olds but stresses more must be done to reach underserved communities and raise awareness about the risks posed by infectious respiratory illnesses.
-
NewsApplied Microbiology International teams up with SelectScience®
Applied Microbiology International (AMI) has announced a new partnership with laboratory science publisher SelectScience®. The two organisations will be working together on SelectScience’s upcoming CLINICAL24 campaign and beyond.
-
NewsReport recommends ‘highly ambitious enterprise’ to create world-leading UK Microbiome Biobank
A new report calls for a ’highly ambitious enterprise’ to create a microbiome biobank that will contribute significantly to the advancement of science and its application to human health.
-
NewsConscience announces top performers in open science challenge to design promising pan-coronavirus drugs
The nonprofit drug discovery biotech Conscience has released seven newly discovered promising early-stage molecules that could lead to a new treatment effective against all coronaviruses, not just SARS-CoV-2.
-
NewsNASA brings space leaders to London to shape future of microgravity research
Leading space experts from around the world gathered at the Royal Institution to discuss the future of microgravity research and prepare for the next generation of human presence in low Earth orbit.
-
NewsChristian Gaebler receives ERC Starting Grant to study HIV patients living without medication
Prof. Christian Gaebler aims to develop treatments that cure HIV infection in patients or prompt the immune system to keep the virus in check in the long term, and has won funding to study patients who are already living without medication.
-
NewsNew guideline for Helicobacter pylori includes change to primary treatment recommendation
New guidelines on the treatment of Helicobacter pylori (H. pylori) infection warn against prescribing PPI triple therapy, instead advising practitioners to use bismuth quadruple therapy or one of the other suggested treatment options.
-
NewsPublic health experts put out call for collaboration in antiviral therapeutics development coalition
Establishing a global therapeutics development coalition is a vital next step to invigorate the therapeutics pipeline and drive advocacy for increased investment and coordination of end-to-end therapeutics development, say a group of public health experts.
-
NewsFirst phase of polio campaign concludes successfully in Gaza
More than 187,000 children under ten years of age were vaccinated with novel oral polio vaccine type 2 (nOPV2) in central Gaza during the first phase of a two-round polio vaccination campaign, conducted between 1–3 September 2024.
-
NewsMeet the Global Ambassadors: Our Q&A with Sergio L Alves jr
The Microbiologist chats with our new Global Ambassador for Brazil, Sergio L Alves jr, Associate Professor at the Federal University of Fronteira Sul (UFFS).
-
NewsWHO data show shock increase in annual cholera deaths
The World Health Organization (WHO) has published global cholera statistics for 2023, showing an increase in cases and deaths.
-
NewsNIH awards will support innovation in syphilis diagnostics
NIAID has awarded grants for 10 projects to improve diagnostic tools for congenital and adult syphilis—conditions currently diagnosed with a sequence of tests, each with limited precision.
-
NewsResearcher explores wastewater’s role in antimicrobial resistance
An Oregon State University researcher will receive $2.35 million from the Environmental Protection Agency to explore what happens to antibiotics, antibiotic-resistant bacteria and their genes after they reach wastewater systems throughout the United States.
-
NewsNew global guidance aims to curb antibiotic pollution from manufacturing
The World Health Organization (WHO) has published its first-ever guidance on antibiotic pollution from manufacturing, focusing on wastewater and solid waste management.
